12:00 AM
 | 
Apr 14, 2011
 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Endocrine disease
Obesity Neuropeptide Y receptor Y2 (NPY2R);...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >